SOHO 2022 | The importance of genomic testing in CLL in the era of novel therapies
Nitin Jain
• 29 Sep 2022
Nitin Jain, MD, University of Texas MD Anderson Cancer Center, Houston, TX, gives an overview of the importance of genomic testing in chronic lymphocytic leukemia (CLL) in the era of novel agents, and further highlights the value of testing for del(17p) with fluorescence in situ hybridization (FISH), as well as IgHV and TP53 mutational status. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
